TY - JOUR
T1 - Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers
AU - Hale, Vanessa L.
AU - Jeraldo, Patricio
AU - Chen, Jun
AU - Mundy, Michael
AU - Yao, Janet
AU - Priya, Sambhawa
AU - Keeney, Gary
AU - Lyke, Kelly
AU - Ridlon, Jason
AU - White, Bryan A.
AU - French, Amy J.
AU - Thibodeau, Stephen N.
AU - Diener, Christian
AU - Resendis-Antonio, Osbaldo
AU - Gransee, Jaime
AU - Dutta, Tumpa
AU - Petterson, Xuan Mai
AU - Sung, Jaeyun
AU - Blekhman, Ran
AU - Boardman, Lisa
AU - Larson, David
AU - Nelson, Heidi
AU - Chia, Nicholas
N1 - Funding Information:
We gratefully acknowledge the following funding sources: NIH (R01CA179243; N.C. and V.L.H. and R01CA170357; L.B.), the Mayo Clinic Center for Cell Signaling in Gastroenterology (NIDDK P30DK084567), the Mayo Clinic Metabolomics Resource Core Pilot and Feasibility Award (U24DK100469), the Fred C. Andersen Foundation (H.N. and N.C.), the Mayo Clinic Center for Individualized Medicine, The Randy Shaver Cancer Research and Community Fund (R.B.), the Minnesota Partnership for Biotechnology and Medical Genomics (R.B.), and the Alfred P. Sloan Foundation (R.B.). O.R.A thanks the financial support coming from the National Institute of Genomic Medicine (INMEGEN) to develop the computational tool used for the microbiome analysis (MICOM).
Publisher Copyright:
© 2018 The Author(s).
PY - 2018/10/31
Y1 - 2018/10/31
N2 - Background: Links between colorectal cancer (CRC) and the gut microbiome have been established, but the specific microbial species and their role in carcinogenesis remain an active area of inquiry. Our understanding would be enhanced by better accounting for tumor subtype, microbial community interactions, metabolism, and ecology. Methods: We collected paired colon tumor and normal-adjacent tissue and mucosa samples from 83 individuals who underwent partial or total colectomies for CRC. Mismatch repair (MMR) status was determined in each tumor sample and classified as either deficient MMR (dMMR) or proficient MMR (pMMR) tumor subtypes. Samples underwent 16S rRNA gene sequencing and a subset of samples from 50 individuals were submitted for targeted metabolomic analysis to quantify amino acids and short-chain fatty acids. A PERMANOVA was used to identify the biological variables that explained variance within the microbial communities. dMMR and pMMR microbial communities were then analyzed separately using a generalized linear mixed effects model that accounted for MMR status, sample location, intra-subject variability, and read depth. Genome-scale metabolic models were then used to generate microbial interaction networks for dMMR and pMMR microbial communities. We assessed global network properties as well as the metabolic influence of each microbe within the dMMR and pMMR networks. Results: We demonstrate distinct roles for microbes in dMMR and pMMR CRC. Bacteroides fragilis and sulfidogenic Fusobacterium nucleatum were significantly enriched in dMMR CRC, but not pMMR CRC. These findings were further supported by metabolic modeling and metabolomics indicating suppression of B. fragilis in pMMR CRC and increased production of amino acid proxies for hydrogen sulfide in dMMR CRC. Conclusions: Integrating tumor biology and microbial ecology highlighted distinct microbial, metabolic, and ecological properties unique to dMMR and pMMR CRC. This approach could critically improve our ability to define, predict, prevent, and treat colorectal cancers.
AB - Background: Links between colorectal cancer (CRC) and the gut microbiome have been established, but the specific microbial species and their role in carcinogenesis remain an active area of inquiry. Our understanding would be enhanced by better accounting for tumor subtype, microbial community interactions, metabolism, and ecology. Methods: We collected paired colon tumor and normal-adjacent tissue and mucosa samples from 83 individuals who underwent partial or total colectomies for CRC. Mismatch repair (MMR) status was determined in each tumor sample and classified as either deficient MMR (dMMR) or proficient MMR (pMMR) tumor subtypes. Samples underwent 16S rRNA gene sequencing and a subset of samples from 50 individuals were submitted for targeted metabolomic analysis to quantify amino acids and short-chain fatty acids. A PERMANOVA was used to identify the biological variables that explained variance within the microbial communities. dMMR and pMMR microbial communities were then analyzed separately using a generalized linear mixed effects model that accounted for MMR status, sample location, intra-subject variability, and read depth. Genome-scale metabolic models were then used to generate microbial interaction networks for dMMR and pMMR microbial communities. We assessed global network properties as well as the metabolic influence of each microbe within the dMMR and pMMR networks. Results: We demonstrate distinct roles for microbes in dMMR and pMMR CRC. Bacteroides fragilis and sulfidogenic Fusobacterium nucleatum were significantly enriched in dMMR CRC, but not pMMR CRC. These findings were further supported by metabolic modeling and metabolomics indicating suppression of B. fragilis in pMMR CRC and increased production of amino acid proxies for hydrogen sulfide in dMMR CRC. Conclusions: Integrating tumor biology and microbial ecology highlighted distinct microbial, metabolic, and ecological properties unique to dMMR and pMMR CRC. This approach could critically improve our ability to define, predict, prevent, and treat colorectal cancers.
UR - http://www.scopus.com/inward/record.url?scp=85055651291&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055651291&partnerID=8YFLogxK
U2 - 10.1186/s13073-018-0586-6
DO - 10.1186/s13073-018-0586-6
M3 - Article
C2 - 30376889
AN - SCOPUS:85055651291
SN - 1756-994X
VL - 10
JO - Genome Medicine
JF - Genome Medicine
IS - 1
M1 - 78
ER -